In the first quarter of 2011, Biofarm posted a net profit of RON7.6 million.
The company said revenue inched down 1.8% on the year to RON28.2 million in January through March, while costs declined 5.4% to RON20 million.
Sales slid 4.6% to RON27.2 million.
Biofarm has a share capital of RON109.4 million split into 1.09 billion shares with a face value of RON0.1.
The company estimates a net profit of RON16.6 million in 2012, 17% higher on the year.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 54% of Biofarm’s shares.
On the Bucharest bourse Monday, Biofarm closed down 3.79% at RON0.1751 a share, amid a declining market. (EUR1=RON4.4373)